Paying the price for cure - Treating cancer survivors with growth hormone

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 12, 2000, Pages 4441-4443

  Sklar, C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHILDHOOD CANCER; EDITORIAL; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; PRIORITY JOURNAL;

ADOLESCENT; CHILD; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; NEOPLASMS; RECURRENCE;

EID: 0034488563     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.12.4441     Document Type: Editorial

References (12)

1. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995
2. Overview of the effects of cancer therapies: The nature, scale, and breadth of the problem
3. Chronic neuroendocrinological sequelae of radiation therapy
4. Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood
5. Effect of long-term recombinant growth hormone therapy in children: The National Cooperative Growth Study USA 1985-1994
6. Mortality and cancer incidence in acromegaly: A retrospective cohort study
7. Role of the insulin-like growth factor family in cancer development and progression
8. Growth hormone and turnout recurrence
9. Is brain tumor recurrence increased following growth hormone treatment?
10. Growth hormone treatment of children with brain tumors and risk of tumor recurrence
11. Risk of second primary neoplasms (SPN) in survivors of childhood cancer: Initial analysis of the Childhood Cancer Survivor Study (CCSS)
12. Growth hormone (GH) replacement therapy: Cancer in adults treated with GH